- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/12 - Gènes codant pour des protéines animales
Détention brevets de la classe C12N 15/12
Brevets de cette classe: 4665
Historique des publications depuis 10 ans
|
185
|
206
|
281
|
389
|
405
|
312
|
289
|
285
|
315
|
102
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20556 |
54 |
| Kyoto University | 2893 |
53 |
| Regeneron Pharmaceuticals, Inc. | 4608 |
49 |
| University Health Network | 1062 |
46 |
| Spiber Inc. | 259 |
42 |
| Osaka University | 3304 |
40 |
| Universite de Montreal | 342 |
35 |
| Keio University | 1120 |
27 |
| The University of Tokyo | 4328 |
27 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 184 |
26 |
| Riken | 1697 |
26 |
| The Johns Hopkins University | 5821 |
24 |
| The Trustees of the University of Pennsylvania | 4406 |
24 |
| The University of British Columbia | 1532 |
23 |
| Takeda Pharmaceutical Company Limited | 2721 |
22 |
| Xlifesc, Ltd. | 47 |
22 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2971 |
21 |
| The General Hospital Corporation | 4824 |
20 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 217 |
20 |
| Kao Corporation | 5025 |
19 |
| Autres propriétaires | 4045 |